✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 拉替拉韦

拉替拉韦

CAS 518048-05-0C20H21FN6O5MW 444.4

拉替拉韦,CAS 登记号 518048-05-0,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号518048-05-0
分子式C20H21FN6O5
分子量444.4
LogP1.1
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 拉替拉韦 的 CAS 号?

本页已列出 拉替拉韦 的 CAS 号:518048-05-0,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

拉替拉韦 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Raltegravir · CAS 518048-05-0 · C20H21FN6O5. UNII 22VKV8053U.

Identification

CAS Registry Number518048-05-0
PubChem CID54671008
Molecular formulaC20H21FN6O5
IUPAC nameN-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
UNII (FDA)22VKV8053U

Computed Descriptors

Molecular Weight444.4
XLogP31.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count6
Exact Mass444.15574595
Monoisotopic Mass444.15574595
Topological Polar Surface Area150
Heavy Atom Count32
Formal Charge0

Physical description & handling notes

  • White to off-white powder; soluble in water; slightly soluble in methanol; very slightly soluble in ethanol and acetonitrile; insoluble in isopropanol /Ratlegarvir potassium/

Regulatory Status

GHS notification summary100% (2 / 2)

GHS Hazard Classification

GHS notification summary100% (2 / 2)

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

Documented Uses

  • Use (kg; approx.) in Germany (2009): >500
  • Consumption (g per capita; approx.) in Germany (2009): 0.00611
  • For the treatment of HIV-1 infection in conjunction with other antiretrovirals.
  • Raltegravir is an integrase inhibitor, the first of the class of antiviral agents active against the human immunodeficiency virus (HIV) that targets the viral integrase. Raltegravir is used in combination with other antiretroviral agents in the treatment of HIV infection. Raltegravir has not been linked convincingly to serum aminotransferase elevations during therapy or to episodes of acute, clinically apparent liver injury.
  • Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiviral Agents; Anti-HIV Agents; Anti-Retroviral Agents; HIV Integrase Inhibitors
  • Antiretrovirals > Integrase inhibitors

Synonyms

Raltegravir; 518048-05-0; MK-0518; MK0518; raltegravirum; DTXSID2048660; MK 0518; CHEBI:82960; 22VKV8053U; DTXCID5028586; L000900612; L-000900612; RefChem:55964; J05AX08; 0518, MK; Raltegravir (MK-0518)

Frequently Asked Questions

What are the CAS number and molecular formula of Raltegravir?

CAS 518048-05-0; molecular formula C20H21FN6O5; molecular weight — g/mol.

What other names is Raltegravir known by?

Raltegravir, 518048-05-0, MK-0518, MK0518, raltegravirum, DTXSID2048660.

Is Raltegravir classified as hazardous?

100% of GHS notifications report no hazard classification (2 of 2).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 拉替拉韦 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1